OBJECTIVES: This study reports the factors that contribute to sternotomy conversions (SCs) and adverse intraoperative events in minimally invasive aortic valve surgery (MI-AVS) and minimally invasive Endoscopic Port Access TM atrioventricular valve surgery (MI-PAS).
INTRODUCTION
We are currently witnessing an evolution in catheter-based aortic- [1, 2] and atrioventricular valve repair [3, 4] and replacement technology [5] , which is paralleled by increasing patient expectations [6] and extensive industry-driven marketing that potentially favour percutaneous approaches above surgical options [7, 8] . The potential benefits associated with minimally invasive valve surgery (MIVS) are now well established [9, 10] , and the contemporary role of conventional sternotomy (or even minimally invasive approaches) for the aortic valve surgery and atrioventricular valve surgery is continuously being redefined. It is now generally accepted that current and future cardiac surgeons need to acquire minimally invasive valve intervention and surgical skills to strengthen their positions in the future treatment of valvular heart disease [11] . MIVS is associated with learning curves and often deter surgeons from incorporating MIVS techniques into clinical practice in a current era of strict quality control and accountability [12] , clinical governance [13, 14] and an increasing patient risk profile [15] . The intention of this study is to provide an in-depth overview of factors that contribute to sternotomy conversion (SC) and adverse intraoperative outcomes during MIVS as part of an ongoing effort to equip surgeons with safe and efficient MIVS risk reduction strategies. †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-10 October 2017.
METHODS
This is a retrospective study of a single-centre MIVS database, in which the reasons for SCs, the incidence of intraoperative major adverse cardiac and cerebrovascular events and the impact of SC on 30-day mortality were defined as primary outcomes. In total, 3780 consecutive patients who required aortic or atrioventricular valve interventions underwent MIVS without exclusion criteria at our institution between 1 February 1997 and 31 March 2016. Minimally invasive aortic valve surgery (MI-AVS) was performed in 908 (24.0%) patients and minimally invasive Endoscopic Port Access TM atrioventricular valve surgery (MI-PAS) in 2872 (76.0%) patients. The relevant preoperative patient characteristics, valve pathology and surgical indications, which include detailed valve analysis for the aortic valve, mitral valve (MV) and tricuspid valve (TV) pathology according to Carpentier (n = 3780) are outlined in Table 1 . The mean body mass index for MI-AVS and MI-PAS patients were 26.5 ± 4.4 m 2 /kg and 25.1 ± 4.5 m 2 /kg, respectively. The mean logistic EuroSCORE was utilized from 1 January 2007, which included 534 MI-AVS (mean 6.1 ± 6.5) and 1713 MI-PAS patients (mean 8.6 ± 12.4) up to date and is outlined in Table 2 . The median logistic EuroSCORE for MI-PAS was 4.5 (range 1.2-98.0).
Surgical techniques-Endoscopic Port Access atrioventricular valve surgery
Our techniques for primary [16, 17] and redo Endoscopic Port Access atrioventricular valve surgeries [18, 19] , peripheral cardiopulmonary bypass (CPB) [20] and endoaortic balloon occlusion [21] include routine preoperative aorta-iliac-femoral axis evaluation by an additional iliac artery contrast injection during cardiac catheterization or by magnetic resonance angiography, venous drainage through the right internal jugular vein (16- TM , Edwards Lifesciences) through which an endoaortic balloon (IntraClude TM , Edwards Lifesciences) is advanced to establish aortic occlusion and delivery of cold antegrade crystalloid cardioplegia. All guidewires and cannulae are advanced and positioned under transoesophageal echocardiography (TOE) guidance, with venous cannulation established first using standard inferior vena cava and bicaval TOE views. Femoral artery cannulation and subsequent endoballoon advancement are guided by standard TOE images of the descending aorta, aortic arch, ascending aorta, sinotubular junction and aortic root. A 4-cm non-rib-spreading working port incision is established over the 4th anterior-axillary intercostal space, and special endoscopic long shafted instruments are utilized to perform standard MV and TV procedures. Argon gas cryoablation (Medtronic, Minneapolis, MN, USA) and left atrial appendage closure are performed in patients with atrial fibrillation or previous stroke. Patent foramen ovale is routinely closed, and post-procedural deairing is accomplished by the left atrial and aortic balloon venting catheters, continuous flooding of the operative field with CO 2 and TOE evaluation for residual air in the left ventricle. Temporary epicardial or transjugular ventricular pacing wires are routinely placed. Preoperative imaging to evaluate lung adhesions are not routinely performed.
Surgical techniques-minimally invasive aortic valve surgery
Our surgical technique for MI-AVS [22] [23] [24] includes a 4-8-cm midline skin incision starting at the manubrium-sternal joint and partial upper J-shaped ministernotomy with an oscillating saw down to either the 3rd or the 4th right intercostal space. Percutaneous femoral and internal jugular veins are utilized for venous drainage and direct antegrade ascending aorta cannulation for arterial inflow. Femoral artery and vein cannulation through a 3-4-cm oblique groin incision may be used in selected patients with short aortas or impaired working space. Cold crystalloid cardioplegia is used in addition to mild systemic cooling (32 C) and delivered through the aortic root for induction and directly in the ostia to maintain arrest. Left ventricle distention is prevented by the intermittent antegrade aortic root venting in cases of severe aortic valve incompetence. Incision and closure of the aorta, valve excision, debridement, suture placement and prosthetic implantation are all performed using standard instrumentation. Extensive decalcification is facilitated by table angle manipulation, careful resection to avoid fragment loss and meticulous saline flushing. Deairing is achieved by continuous CO 2 flooding of the operative field and aortic root vent under TOE surveillance.
Data analysis
All intraoperative data were collected from a prospective database. The continuous and categorical outcomes were assessed by the incidence of adverse events (mean ± standard deviation) and the calculated intraoperative mortality and 30-day mortality. The study was approved by the institutional ethics review committee, and the authors agreed to the manuscript as written and take responsibility for data integrity.
RESULTS

Intraoperative outcomes
In total, 4415 MIVS procedures (MI-AVS = 908 and MI-PAS = 3507) were performed in 3780 consecutive patients as isolated or combined valvular procedures per patient and included 1537 valve replacements (MI-AVS = 896 and MI-PAS = 641) and 2878 valve repairs (MI-AVS = 12 and MI-PAS = 2866). The procedures performed are outlined in Table 3 . The mean CPB and ischaemic times are described in Table 4 . MI-PAS consisted of 2183 (76.0%), 54 (1.9%) and 635 (22.1%) isolated MV, isolated TV and combined MV and TV procedures, respectively. The MV repair was achieved in 96.4% (n = 1822 of 1891) of primary annular dilatation and degenerative valves and constituted 81.7% (n = 2866) of all MI-PAS procedures (n = 3507). SC was required in 114 of 3780 (3.0%) patients that underwent MIVS, of which MI-AVS and MI-PAS constituted 28 (0.7%) and 86 (2.3%), respectively. SC rates during the initial 4-year learning curves were 3.7% (n = 7 of 188) and 3.3% (n = 14 of 421) for MI-AVS and MI-PAS, respectively. The reasons for SC are outlined in Table 5 . Conversions that occurred prior to cross-clamping or endoballoon inflation are considered as a 'risk aversion strategy change' or early conversions, whereas late conversions are defined as conversions during/after cross-clamping. For MI-PAS, SC was required in 54 (2.5%), 2 (4.6%) and 30 (4.7%) isolated MV (n = 2183), TV (n = 54) and combined MV and TV (n = 635) procedures, respectively. Reasons for SC in the isolated MV surgery (n = 54) included poor visualization (n = 2, 3.7%), bleeding (n = 4, 7.4%), lung adhesions (n = 23, 42.6%), cannulation difficulty (n = 15, 27.8%), aorta dissection (n = 8, 14.8%) and atrioventricular dehiscence (n = 2, 3.7%). Intraoperative major adverse cardiac and cerebrovascular events for the series (n = 3780) and SC (n = 114) are outlined in Table 6 . Significant intraoperative neurological deficit occurred in 1 (0.1%) and 3 (3.5%) MI-AVS and MI-PAS conversions, respectively.
The impact of conversion on intraoperative mortality and 30-day mortality
The operative mortalities for the total MI-AVS (n = 908) and MI-PAS (n = 2872) series were 2.0% (n = 18) and 2.6% (n = 74), respectively. No operative or 30-day mortalities were observed in patients who required MI-AVS conversions (n = 28). The 30-day mortality and total in-hospital mortality associated with SC in MI-PAS (n = 86) were 10.5% (n = 9) and 15.1% (n = 13), respectively, in which intraoperative mortality occurred in 5 (5.8%) patients and postoperative mortality in 8 (9.3%) patients. Intraoperative mortalities occurred secondary to atrioventricular dehiscence (n = 2, 2.3%), ventricle rupture (n = 1, 1.2%) and aortic dissection (n = 2, 2.3%). Late postoperative mortalities occurred in SC for aortic dissection (n = 2, 2.3%, Days 1 and 38) and low cardiac output syndrome (n = 6, 7.0%, Days 1, 2, 4, 8, 43 and 59).
DISCUSSION
The potential benefits associated with MIVS are now well established [9, 10] , and the future relevance of conventional sternotomy access for valve surgery is continuously being redefined. It is generally accepted that cardiac surgeons need to improve their skills in catheter-based and minimally invasive approaches to remain relevant in the treatment of valvular heart disease in the current era [11] . However, strict quality control [12] , clinical governance, increasing patient expectations, an aging population with increased comorbidities and extensive industry-driven marketing that favour 'no surgeon required' technology are not conducive for acquiring MIVS skills [13] [14] [15] . Our MI-AVS programme was initiated in October 1997 and constitutes 24.0% (n = 908) of our MIVS programme (n = 3780) at present. We established the partial upper J-ministernotomy approach as our preferred technique irrespective of body habitus, anatomical variation, presentation or patient risk profile, which is not the case for other MI-AVS approaches [25] . It offers circumferential access to the aorta and right atrium, even in obese patients (n = 173, 19.1%) and allows for easy conversion to full sternotomy if required, which occurred in 28 (3.1%) patients. Poor visualization accounted for 4 (0.4%) SCs, which we limit by elevating the upper body, strategically placed retraction sutures and theatre table angle adjustments. Placement of annular U-sutures follows the same rules as in standard procedures, with the insertion of 3 initial commissural sutures often optimizing exposition. Cannulation-related SC occurred in 7 (0.8%) patients, which emphasizes the importance of advancing all guidewires and cannula under skilled TOE surveillance, careful tactile manipulation and refraining from forcing wires through areas of resistance. The porcelain aorta, which can be predicted by routine chest radiography [26] , required deep hypothermic arrest by SC in 2 (0.2%) patients. In our opinion, MI-AVS is not recommended in cases where an aortic cross-clamp cannot be safely applied. Aortotomy bleeding required SC in 9 (1.0%) patients and can be minimized by using 2 running sutures and by ensuring haemostasis and control before discontinuing CPB. Resistant arrhythmias resulted in 3 (0.3%) conversions, which can be reduced by appropriate pharmacological interventions, the application of external defibrillation paddles and the use of paediatric internal shock paddles. We also routinely placed temporary pacemaker wires on the right ventricle prior to declamping. Even though SC was required for prosthetic dysfunction (n = 1, 0.1%), for root enlargement (n = 1, 0.1%) and for an aortic interposition graft (n = 1, 0.1%), the feasibility of MI-AVS in these contexts are well described [23] . Conversion rates improved rapidly following the initial 4-year learning curve of 3.7% (n = 7 of 188). MI-AVS SC had no impact on 30-day mortality. Our MI-PAS programme was initiated in February 1997 and constitutes 76.0% (n = 2872) of our MIVS programme at present. It allows focused endoscopic access to the atrioventricular valves with perioperative and long-term results equal to or better than conventional sternotomy outcomes [27] . It is considered by many to pose the most extensive MIVS learning curve and requires dedication, commitment and technical development of the whole operating team. Systematic valve evaluation, guidewire advancement and peripheral cannula placement under TOE surveillance are invaluable and considered to be a prerequisite in ensuring safe and sustainable programmes. Adverse early-and late intraoperative events that required SC occurred in 86 (3.0%) patients. The initial 4-year learning curve conversion rate was 3.3% (n = 14 of 421). Lung adhesions accounted for 35 (1.2%) SCs, which occurred in the context of primary (n = 2507, 87.3%), redo cardiac (n = 365, 12.7%) and redo PAS (60, 2.1%) procedures. Previous right hemithorax interventions are not considered as contraindications, and we do not routinely perform any special imaging investigations to identify lung adhesions. Targeted access to the valves is obtained by careful release of anterior, mediastinal and diaphragm adhesions without causing pulmonary tears or bleeding. Poor visualization resulted in SC in 2 (0.1%) patients and can be avoided by ensuring the correct placement of camera, working and retractor ports, with strategic placement of retraction sutures and appropriate table positioning, as valuable adjuncts. Obesity (n = 316, 11%) is not considered as a contraindication but is not recommended in the early learning experience. Cannulation challenges required SC in 36 (1.3%) patients and included the early identification of guidewire advancement resistance (n = 17, 0.6%) and insufficient CPB flow (n = 6, 0.2%), with aortic dissection occurring in 11 (0.3%) patients during the initial learning curve and which also accounted for 2 (0.1%) intraoperative mortalities associated with SC in our series. A low threshold to convert single to bilateral femoral artery cannulation ensures safe CPB and perfusion pressures in cases of insufficient CPB flow. The importance of TOE has already been emphasized, and controlled guidewire advancement techniques are of utmost importance [28, 29] . Bleeding accounted for 7 (0.2%) SCs, which included pacemaker placement-related right ventricle perforation (n = 3, 0.1%) and atriotomy bleeding (n = 4, 0.1%). We recommend temporary pacemaker placement on the diaphragmatic aspect of the muscular left ventricle, which limits the risk of right ventricle bleeding. The right atrium is closed by 2 running sutures and the left atrium by a single layer. A single event of endoaortic balloon rupture by suture puncture (0.03%) due to non-coronary sinus displacement required SC. It can be avoided by careful initial TOE-guided placement at the sinotubular junction, inflation under TOE guidance, confirmation of position prior to left atriotomy and careful annular suture placement between the anterolateral commissure and the A2 segment. Atrioventricular dehiscence occurred in 5 (0.2%) patients, which were repaired by valve reimplantation following SC. Severe posterior annular calcification can be identified by routine preoperative imaging and should be resected with extreme caution [30] .
Limitations
This series reflects the outcomes of a single centre with extensive experience on MI-AVS and MI-PAS. The use of sternotomy access was abandoned since the introduction of our respective MI-AVS and MI-PAS programmes, which are routine for isolated aortic valve disease and atrioventricular valve disease at our institution. All patients were offered these interventions with the intention of treating, which resulted in the absence of a control group or propensity matching. The mean logistic EuroSCORE, which is standardized for sternotomy access, was utilized as control group for operative outcomes. The initial 4-year learning curves reported in this series are descriptive and were not subjected to the cumulative sum control chart (CUSUM) analysis or other statistical methodology. It is our intention to provide a platform for current and future surgeons to adapt and adopt MIVS into their routine surgical practice.
CONCLUSION
MIVS is evolving and increasingly being recognized as the 'goldstandard' for surgical valve interventions in the context of rapidly expanding catheter-based technology and increasing patient expectations. Surgeons need to be aware of factors that contribute to SC and adverse intraoperative outcomes to ensure that patients enjoy the maximum potential benefit of MIVS by applying effective risk reduction strategies that encourage safer and sustainable MIVS programmes as part of an ongoing effort to strengthen our positions as surgeons in the future of valvular heart disease interventions.
